The panel discussing Ambrish Mithal and Shivam Vij’s book on obesity and weight loss drugs included Minister of State Jitendra Singh, actor Sharmila Tagore, and HT Media chairperson Shobhana Bhartia.
Lilly said in June it received approval from India’s drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo Nordisk launched Wegovy in a similar pen device.
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.
The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials internationally. The court asked DCGI to submit report within 3 months.
Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been reported in Michigan, US, and Santiago de Copostela, Spain.
Discriminatory laws limit firms from hiring willing women, and removing such barriers can help narrow the economic gap between developing and developed countries.
While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.
A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS